A controlled trial of venlafaxine in trichotillomania: interim phase I results
Ninan, P.T.; Knight, B.; Kirk, L.; Rothbaum, B.O.; Kelsey, J.; Nemeroff, C.B.
Psychopharmacology Bulletin 34(2): 221-224
1998
ISSN/ISBN: 0048-5764 PMID: 9641004 Document Number: 496489
This article reports the preliminary findings of a two-phase trial examining the efficacy of venlafaxine in trichotillomania. Phase 1 is a 12-week, open-label, prospective trial of venlafaxine in trichotillomania. Venlafaxine was effective in significantly reducing the symptoms of trichotillomania; 8 of 12 patients were considered responders. The implications of the efficacy of venlafaxine in trichotillomania are discussed, including its important advantages over other available antidepressant and anxiolytic medications.
Document emailed within 1 workday
Related Documents
Mittra, I.; Mishra, G.A.; Singh, S.; Aranke, S.; Notani, P.; Badwe, R.; Miller, A.B.; Daniel, E.E.; Gupta, S.; Uplap, P.; Thakur, M.H.; Ramani, S.; Kerkar, R.; Ganesh, B.; Shastri, S.S. 2010: A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening International Journal of Cancer 126(4): 976-984Tesar, G.E.; Rosenbaum, J.F.; Pollack, M.H.; Herman, J.B.; Sachs, G.S.; Mahoney, E.M.; Cohen, L.S.; McNamara, M.; Goldstein, S. 1987: Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial Journal of Clinical Psychiatry 48 Suppl: 16-21
Mantero, J.C.; Kishore, N.; Ziemek, J.; Stifano, G.; Zammitti, C.; Khanna, D.; Gordon, J.K.; Spiera, R.; Zhang, Y.; Simms, R.W.; Lafyatis, R. 2018: Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. a phase I/Ii biomarker trial Clinical and Experimental Rheumatology 36 Suppl 113(4): 146-149
Elfenbein, G.; Krischer, J.; Babington, R.; Hong, R.; Jansen, J.; Lazarus, H.; Winton, E.; Rand, K. 1989: Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation Transplantation Proceedings 21(1 Pt 3): 3099-3100
Sagirkaya, E.; Arikan, S.; Sadik, B.; Kara, C.; Karasoy, D.; Cehreli, M. 2012: A randomized, prospective, open-ended clinical trial of zirconia fixed partial dentures on teeth and implants: interim results International Journal of Prosthodontics 25(3): 221-231
2016: Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases Clinical Advances in Hematology and Oncology: H&o 14(4 Suppl. 5): 3-7
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Mease, P.J.; Russell, I.J.; Arnold, L.M.; Florian, H.; Young, J.P.; Martin, S.A.; Sharma, U. 2008: A randomized, double-blind, placebo-controlled, phase IIi trial of pregabalin in the treatment of patients with fibromyalgia Journal of Rheumatology 35(3): 502-514
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Dayan, S.H.; Arkins, J.P.; Sharma, V.; Paterson, E.; Barnes, D. 2011: A phase 2, double-blind, randomized, placebo-controlled trial of a novel nutritional supplement product to promote healthy skin Journal of Drugs in Dermatology: Jdd 10(10): 1106-1114
Matthews, L.T.; Sibeko, S.; Mansoor, L.E.; Yende-Zuma, N.; Bangsberg, D.R.; Karim, Q.A. 2013: Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial Plos one 8(3): E56400
Hengge, U.R.; Goos, M.; Esser, S.; Exner, V.; Dötterer, H.; Wiehler, H.; Borchard, C.; Müller, K.; Beckmann, A.; Eppner, M.T.; Berger, A.; Fiedler, M. 1998: Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients Aids 12(17): F225-F234
Young, S.A.; Hurt, P.H.; Benedek, D.M.; Howard, R.S. 1998: Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial Journal of Clinical Psychiatry 59(2): 76-80
Plewig, G.; Cunliffe, W.J.; Binder, N.; Höschen, K. 2009: Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase IIi trial Contraception 80(1): 25-33
Korman, D.B.; Mikaélian, S.G.; Boronovskaia, L.E.; Maslova, I.A. 2004: Results of a phase I-Ii clinical trial of Emoxyl, a novel antineoplastic anthracycline Voprosy Onkologii 50(2): 202-207
Wang, J.; Zhang, H.; Sun, Y. 1996: Results of phase II clinical trial of vindesine in the treatment of malignant tumors Zhonghua Zhong Liu Za Zhi 18(4): 285-288
Agnandji, S.Todagbe.; Lell, B.; Soulanoudjingar, S.Solmeheim.; Fernandes, Jé.Francisco.; Abossolo, Béatrice.Peggy.; Conzelmann, C.; Methogo, B.Gaelle.Nfono.Ondo.; Doucka, Y.; Flamen, A.; Mordmüller, B.; Issifou, S.; Kremsner, P.Gottfried.; Sacarlal, J.; Aide, P.; Lanaspa, M.; Aponte, J.J.; Nhamuave, A.; Quelhas, D.; Bassat, Q.; Mandjate, S.; Macete, Eébio.; Alonso, P.; Abdulla, S.; Salim, N.; Juma, O.; Shomari, M.; Shubis, K.; Machera, F.; Hamad, A.Said.; Minja, R.; Mtoro, A.; Sykes, A.; Ahmed, S.; Urassa, A.Martin.; Ali, A.Mohammed.; Mwangoka, G.; Tanner, M.; Tinto, H 2011: First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children New England Journal of Medicine 365(20): 1863-1875
Luckett, T.; Phillips, J.; Agar, M.; Lam, L.; Davidson, P.M.; McCaffrey, N.; Boyle, F.; Shaw, T.; Currow, D.C.; Read, A.; Hosie, A.; Lovell, M. 2018: Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial Bmc Health Services Research 18(1): 558
Patel, N.; Jagannath, K.; Vora, A.; Patel, M.; Patel, A. 2017: A Randomized, Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Tolerability of Risorine with Conventional Rifampicin in the Treatment of Newly Diagnosed Pulmonary Tuberculosis Patients Journal of the Association of Physicians of India 65(9): 48-54